These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15249925)

  • 1. Pharmacogenetic approaches to rheumatoid arthritis.
    Taniguchi A; Kamatani N
    Pharmacogenomics J; 2004; 4(6):350-3. PubMed ID: 15249925
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacogenomics of methotrexate in rheumatoid arthritis: does race make a difference?
    Dervieux T
    J Rheumatol; 2008 Apr; 35(4):550-2. PubMed ID: 18398948
    [No Abstract]   [Full Text] [Related]  

  • 3. Comment on: Methotrexate pharmacogenomics in rheumatoid arthritis: introducing false positive report probability.
    Beretta L
    Rheumatology (Oxford); 2009 Dec; 48(12):1619-20; author reply 1620. PubMed ID: 19828599
    [No Abstract]   [Full Text] [Related]  

  • 4. Race and methotrexate pharmacogenetics in rheumatoid arthritis.
    Ranganathan P; McLeod H
    J Rheumatol; 2010 May; 37(5):1064; author reply 1065. PubMed ID: 20439524
    [No Abstract]   [Full Text] [Related]  

  • 5. Do snapshot statistics fool us in MTX pharmacogenetic studies in arthritis research?
    de Rotte MC; Luime JJ; Bulatovic M; Hazes JM; Wulffraat NM; de Jonge R
    Rheumatology (Oxford); 2010 Jun; 49(6):1200-1. PubMed ID: 20110251
    [No Abstract]   [Full Text] [Related]  

  • 6. Can rheumatoid arthritis responsiveness to methotrexate and biologics be predicted?
    Bansard C; Lequerré T; Daveau M; Boyer O; Tron F; Salier JP; Vittecoq O; Le-Loët X
    Rheumatology (Oxford); 2009 Sep; 48(9):1021-8. PubMed ID: 19483089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacogenetics of methotrexate.
    Hider SL; Bruce IN; Thomson W
    Rheumatology (Oxford); 2007 Oct; 46(10):1520-4. PubMed ID: 17586865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on pharmacogenomics in rheumatoid arthritis with a focus on TNF-blocking agents.
    Ranganathan P
    Curr Opin Mol Ther; 2008 Dec; 10(6):562-7. PubMed ID: 19051134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenomics in rheumatoid arthritis.
    Ranganathan P
    Methods Mol Biol; 2008; 448():413-35. PubMed ID: 18370240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personalized medicine in rheumatoid arthritis: hopes and challenges.
    Bridges SL
    Bull NYU Hosp Jt Dis; 2007; 65(3):174-7. PubMed ID: 17922665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics and the impact on treatment protocols in patients with rheumatoid arthritis.
    Ibrahim I; Owen SA; Barton A
    Expert Rev Clin Immunol; 2012 Aug; 8(6):509-11. PubMed ID: 22992143
    [No Abstract]   [Full Text] [Related]  

  • 12. Leveraging human genetics to develop future therapeutic strategies in rheumatoid arthritis.
    Plenge RM; Raychaudhuri S
    Rheum Dis Clin North Am; 2010 May; 36(2):259-70. PubMed ID: 20510233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic markers of treatment response in rheumatoid arthritis.
    Bridges SL
    Arthritis Rheum; 2004 Apr; 50(4):1019-22. PubMed ID: 15077282
    [No Abstract]   [Full Text] [Related]  

  • 14. Factors influencing response to disease modifying antirheumatic drugs in patients with rheumatoid arthritis.
    Hider SL; Buckley C; Silman AJ; Symmons DP; Bruce IN
    J Rheumatol; 2005 Jan; 32(1):11-16. PubMed ID: 15700388
    [No Abstract]   [Full Text] [Related]  

  • 15. Methotrexate pharmacogenetics: the first step toward individualized therapy in rheumatoid arthritis.
    Ranganathan P; McLeod HL
    Arthritis Rheum; 2006 May; 54(5):1366-77. PubMed ID: 16645965
    [No Abstract]   [Full Text] [Related]  

  • 16. Comment on: The pharmacogenetics of methotrexate.
    van der Kooij SM; Wessels JA; Huizinga TW; Guchelaar HJ
    Rheumatology (Oxford); 2008 Apr; 47(4):557; author reply 5557-8. PubMed ID: 18222982
    [No Abstract]   [Full Text] [Related]  

  • 17. Gene analysis for exploring the effects of drugs in rheumatoid arthritis.
    Ospelt C; Neidhart M; Gay RE; Gay S
    Arthritis Rheum; 2005 Aug; 52(8):2248-56. PubMed ID: 16052564
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacogenetic and pharmacogenomic treatment of rheumatoid arthritis: a review of Pharmacogenomics Knowledge Base scientific evidence.
    Dorado P; M Peñas-Lledó E
    Pharmacogenomics; 2024 Jan; 25(2):55-58. PubMed ID: 38230665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of low dose methotrexate in rheumatoid arthritis - are we entering a new era of therapeutic drug monitoring and pharmacogenomics?
    Stamp L; Roberts R; Kennedy M; Barclay M; O'Donnell J; Chapman P
    Biomed Pharmacother; 2006 Dec; 60(10):678-87. PubMed ID: 17071051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetic and metabolite measurements are associated with clinical status in patients with rheumatoid arthritis treated with methotrexate: results of a multicentred cross sectional observational study.
    Dervieux T; Furst D; Lein DO; Capps R; Smith K; Caldwell J; Kremer J
    Ann Rheum Dis; 2005 Aug; 64(8):1180-5. PubMed ID: 15677700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.